Koninklijke Philips (NYSE:PHG) Upgraded by StockNews.com to Buy Rating

Koninklijke Philips (NYSE:PHG) was upgraded by investment analysts at StockNews.com from a “hold” rating to a “buy” rating in a report issued on Thursday.

PHG has been the subject of several other reports. UBS Group upgraded Koninklijke Philips from a “neutral” rating to a “buy” rating in a research report on Thursday. Jefferies Financial Group raised shares of Koninklijke Philips from an “underperform” rating to a “hold” rating in a report on Tuesday, October 29th. Three investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat, Koninklijke Philips has a consensus rating of “Moderate Buy”.

Koninklijke Philips Price Performance

PHG stock traded down $0.02 during mid-day trading on Thursday, hitting $25.04. The stock had a trading volume of 970,126 shares, compared to its average volume of 667,555. The firm has a fifty day simple moving average of $26.25 and a 200 day simple moving average of $28.16. The firm has a market capitalization of $23.53 billion, a P/E ratio of -59.61, a P/E/G ratio of 0.93 and a beta of 0.77. The company has a current ratio of 1.16, a quick ratio of 0.74 and a debt-to-equity ratio of 0.60. Koninklijke Philips has a 52 week low of $19.55 and a 52 week high of $32.91.

Koninklijke Philips (NYSE:PHG) last announced its quarterly earnings data on Wednesday, February 19th. The technology company reported $0.54 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.55 by ($0.01). Koninklijke Philips had a negative net margin of 1.83% and a positive return on equity of 10.11%. The firm had revenue of $5.38 billion during the quarter, compared to the consensus estimate of $5.10 billion. As a group, research analysts forecast that Koninklijke Philips will post 1.43 EPS for the current year.

Institutional Investors Weigh In On Koninklijke Philips

A number of hedge funds and other institutional investors have recently bought and sold shares of PHG. FMR LLC raised its position in Koninklijke Philips by 0.6% in the third quarter. FMR LLC now owns 6,138,708 shares of the technology company’s stock valued at $200,859,000 after purchasing an additional 35,935 shares during the last quarter. Creative Planning raised its holdings in Koninklijke Philips by 39.3% in the 3rd quarter. Creative Planning now owns 84,263 shares of the technology company’s stock valued at $2,757,000 after buying an additional 23,768 shares during the last quarter. JPMorgan Chase & Co. boosted its position in Koninklijke Philips by 315.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 245,729 shares of the technology company’s stock worth $8,040,000 after buying an additional 186,520 shares during the period. International Assets Investment Management LLC bought a new stake in Koninklijke Philips during the 3rd quarter worth approximately $1,360,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new stake in Koninklijke Philips during the 3rd quarter worth approximately $4,622,000. Institutional investors own 13.67% of the company’s stock.

About Koninklijke Philips

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.